Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2007 2
2008 1
2010 1
2011 2
2012 1
2015 1
2016 1
2017 5
2018 9
2019 5
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Targeting invadopodia for blocking breast cancer metastasis.
Meirson T, Gil-Henn H. Meirson T, et al. Among authors: gil henn h. Drug Resist Updat. 2018 Jul;39:1-17. doi: 10.1016/j.drup.2018.05.002. Epub 2018 May 17. Drug Resist Updat. 2018. PMID: 30075834 Review.
Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation.
Ninio L, Nissani A, Meirson T, Domovitz T, Genna A, Twafra S, Srikanth KD, Dabour R, Avraham E, Davidovich A, Gil-Henn H, Gal-Tanamy M. Ninio L, et al. Among authors: gil henn h. Cells. 2019 Nov 5;8(11):1395. doi: 10.3390/cells8111395. Cells. 2019. PMID: 31694343 Free PMC article.
Invasion and metastasis: the elusive hallmark of cancer.
Meirson T, Gil-Henn H, Samson AO. Meirson T, et al. Among authors: gil henn h. Oncogene. 2020 Feb;39(9):2024-2026. doi: 10.1038/s41388-019-1110-1. Epub 2019 Nov 19. Oncogene. 2020. PMID: 31745295 No abstract available.
Oral inflammation promotes oral squamous cell carcinoma invasion.
Goertzen C, Mahdi H, Laliberte C, Meirson T, Eymael D, Gil-Henn H, Magalhaes M. Goertzen C, et al. Among authors: gil henn h. Oncotarget. 2018 Jun 26;9(49):29047-29063. doi: 10.18632/oncotarget.25540. eCollection 2018 Jun 26. Oncotarget. 2018. PMID: 30018735 Free PMC article.
Tumor cell density regulates matrix metalloproteinases for enhanced migration.
Jayatilaka H, Umanzor FG, Shah V, Meirson T, Russo G, Starich B, Tyle P, Lee JSH, Khatau S, Gil-Henn H, Wirtz D. Jayatilaka H, et al. Among authors: gil henn h. Oncotarget. 2018 Aug 24;9(66):32556-32569. doi: 10.18632/oncotarget.25863. eCollection 2018 Aug 24. Oncotarget. 2018. PMID: 30220965 Free PMC article.
L-Norvaline, a new therapeutic agent against Alzheimer's disease.
Polis B, Srikanth KD, Gurevich V, Gil-Henn H, Samson AO. Polis B, et al. Among authors: gil henn h. Neural Regen Res. 2019 Sep;14(9):1562-1572. doi: 10.4103/1673-5374.255980. Neural Regen Res. 2019. PMID: 31089055 Free PMC article.
Invadopodia: the leading force.
Sibony-Benyamini H, Gil-Henn H. Sibony-Benyamini H, et al. Among authors: gil henn h. Eur J Cell Biol. 2012 Nov-Dec;91(11-12):896-901. doi: 10.1016/j.ejcb.2012.04.001. Epub 2012 May 24. Eur J Cell Biol. 2012. PMID: 22633185 Free article. Review.
Targeting invadopodia-mediated breast cancer metastasis by using ABL kinase inhibitors.
Meirson T, Genna A, Lukic N, Makhnii T, Alter J, Sharma VP, Wang Y, Samson AO, Condeelis JS, Gil-Henn H. Meirson T, et al. Among authors: gil henn h. Oncotarget. 2018 Apr 24;9(31):22158-22183. doi: 10.18632/oncotarget.25243. eCollection 2018 Apr 24. Oncotarget. 2018. PMID: 29774130 Free PMC article.
FAK family kinases: The Yin and Yang of cancer cell invasiveness.
Genna A, Gil-Henn H. Genna A, et al. Among authors: gil henn h. Mol Cell Oncol. 2018 May 25;5(4):e1449584. doi: 10.1080/23723556.2018.1449584. eCollection 2018. Mol Cell Oncol. 2018. PMID: 30250911 Free PMC article.
Commentary on Giralt et al.: PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
Polis B, Gil-Henn H. Polis B, et al. Among authors: gil henn h. Exp Neurol. 2019 Jan;311:313-317. doi: 10.1016/j.expneurol.2018.08.011. Epub 2018 Aug 29. Exp Neurol. 2019. PMID: 30171866
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page